Search clinical trials for: Infliximab biosimilar

Total 1039 results

Onze Lieve Vrouwe Gasthuis
Santeon

Unknown

"Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial" (SIMILAR)

Crohn's Disease | Colitis, Ulcerative
Services Institute of Medical Sciences, Pakistan

Completed

Efficacy and Safety of Infliximab Biosimilar in the Treatment of Resistant Hidradenitis Suppurativa

Hidradenitis Suppurativa

Pakistan
Diakonhjemmet Hospital
South-Eastern Norway Regional Health Authority

Completed

The NOR-SWITCH Study (NOR-SWITCH)

Rheumatoid Arthritis | Crohn's Disease | Ulcerative Colitis | Psoriatic Arthritis | Spondyloarthritis | Psoriasis Chronic

Norway
Samsung Bioepis Co., Ltd.

Completed

A Study Comparing SB2 to Remicade® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy

Rheumatoid Arthritis

Bulgaria, Lithuania
Hikma Pharmaceuticals LLC
Syneos Health

Completed

Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan (PASSRRA)

Rheumatoid Arthritis

Jordan
Pfizer

Completed

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)

Psoriasis Vulgaris | Pustular Psoriasis | Psoriasis Arthropathica | Erythrodermic Psoriasis

Japan
Pfizer

Completed

Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)

Crohn's Disease | Ulcerative Colitis

Japan
Pfizer

Active, not recruiting

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)

Rheumatoid Arthritis

Japan
Oslo University Hospital
Vestre Viken Hospital Trust; University Hospital of North Norway; Diakonhjemmet... and other collaborators

Completed

BackToBasic: Infliximab in Chronic Low Back Pain and Modic Changes

Low Back Pain

Norway
McGill University Health Centre/Research Institute...
University of Manitoba; University of British Columbia; Alberta Health services; Université de Sherbrooke and other collaborators

Unknown

Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs

Rheumatoid Arthritis | Crohn's Disease | Ulcerative Colitis | Ankylosing Spondylitis

Canada
Hanyang University Seoul Hospital
Linical Korea

Not yet recruiting

REduCed Dose of TNFi in Patients With Ankylosing SpondyliTis (RECAST)

Ankylosing Spondylitis | Axial Spondyloarthritis
Janssen Scientific Affairs, LLC

Completed

Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid Arthritis (AWARE)

Arthritis, Rheumatoid

United States
Merck Sharp & Dohme LLC
Integrated Therapeutics Group

Terminated

Re³ (Re-Cube: Retain Remicade® Response)(Study P04249AM3) (Re³)

Rheumatoid Arthritis
Pfizer

Completed

A Pharmacokinetics Study Comparing PF-06438179 and Infliximab in Healthy Volunteers (REFLECTIONS B537-01)

Healthy

United States
NYU Langone Health

Withdrawn

Managing Infliximab Reinduction After Temporary Discontinuation of Drug

Inflammatory Bowel Disease
Centre hospitalier de l'Université de Montréal...
Ottawa Hospital Research Institute; Maisonneuve-Rosemont Hospital; Niagara Health... and other collaborators

Recruiting

Topical Infliximab in Eyes With Penetrating Keratoplasty

Glaucoma Following Surgery

Canada
European Organisation for Research and Treatment...

Completed

Infliximab in Treating Patients With Myelodysplastic Syndrome

Myelodysplastic Syndromes

France, Belgium, Netherlands, Czech Republic, Italy, Germany
Janssen Research & Development, LLC
Janssen Biologics BV

Completed

A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients

Ulcerative Colitis

United States, France, United Kingdom, Belgium, Switzerland, Israel, Canada, Australia, Netherlands, New Zealand, Austria, Germany, Denmark, Czechia, Argentina
Biocad

Completed

Comparative Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis

Russian Federation, Belarus
Asan Medical Center

Recruiting

TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease

Crohn Disease | Therapeutic Drug Monitoring | Infliximab | Perianal Fistula Due to Crohn's Disease | Magnetic Resonance Novel Index for Fistula Imaging in Crohn's Disease Score

Korea, Republic of
Centocor, Inc.

Completed

A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis

Ulcerative Colitis

United States, Belgium, Canada, Netherlands, Denmark
Centocor, Inc.
Centocor BV

Completed

A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease

Crohn Disease
Rheumazentrum Ruhrgebiet
PPD; Centocor BV; Trial Coordination Center, 9713 GZ Groningen

Unknown

Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis

Belgium, Germany, Finland, France, Netherlands, United Kingdom
Epirus Biopharmaceuticals (Switzerland) GmbH

Unknown

BOW015 (Infliximab-EPIRUS) and Infliximab in Patients With Active Rheumatoid Arthritis: The UNIFORM Study

Rheumatoid Arthritis
Tufts Medical Center
National Institutes of Health (NIH)

Completed

A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).

COVID-19

United States
Centocor, Inc.
Centocor BV

Completed

A Long-term Safety Study of Infliximab (Remicade)

Arthritis, Rheumatoid | Psoriasis | Crohn Disease

United States, Canada, France, Germany, Poland, United Kingdom, Belgium, Spain, Argentina, Israel, Switzerland, Finland, Sweden, Netherlands, Austria, Hungary, Ireland, Norway, Denmark
Centocor, Inc.

Completed

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis

Psoriasis
Merck Sharp & Dohme LLC

Terminated

Treatment With Infliximab in a Medical Setting (Study P05587) (OPTIMIST)

Crohn's Disease
Pfizer

Completed

A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).

Rheumatoid Arthritis

Jordan, Korea, Republic of, United States, Poland, Japan, Hungary, South Africa, Ukraine, Germany, Israel, Philippines, Serbia, Australia, Georgia, Czechia, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Guatemala, Lithuania, M... and more
Xiaomin Zhang

Active, not recruiting

A Clinical Trial of Infliximab for Childhood Uveitis

Uveitis | Infliximab
Egla C. Rabinovich
Childhood Arthritis and Rheumatology Research Alliance

Completed

Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis

Chronic Uveitis

United States
Loyola University

Withdrawn

Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)

Toxic Epidermal Necrolysis
Peking Union Medical College Hospital
Changhai Hospital; West China Hospital; Shenzhen People's Hospital; First People... and other collaborators

Unknown

Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid Arthritis (ULTRA)

Rheumatoid Arthritis | Ultrasonography | Infliximab

China
Center for Integrated Rehabilitation and Organ...
Centocor, Inc.

Completed

Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia

Cachexia | COPD

Netherlands
Cares, Kristen, M.D.

Recruiting

Infliximab Proactive Drug Monitoring in the Pediatric IBD Population

Inflammatory Bone Disease

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab (PRECISION)

Inflammatory Bowel Disease

Netherlands
James Chodosh, MD, MPH
Massachusetts Eye and Ear Infirmary; Fonds de recherche en ophtalmologie de...

Withdrawn

Topical Infliximab in Autoimmune Eyes With Keratoprosthesis

Stevens-Johnson Syndrome | Mucous Membrane Pemphigoid | Toxic Epidermal Necrolysis (Lyell) Syndrome

United States, Canada
Centocor, Inc.

Completed

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease

Crohn Disease
Centocor, Inc.

Completed

A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease

Crohn Disease
Florida Academic Dermatology Centers

Completed

Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis Suppurtativa (HS2006)

Hidradenitis Suppurativa

United States
University of Athens

Terminated

Treatment of Refractory Diabetic Macular Edema With Infliximab

Diabetic Retinopathy | Diabetic Macular Edema | Visual Acuity

Greece
University Hospital, Tours

Completed

Pharmaco Kinetic Variability of Infliximab in Rheumatoid Arthritis (FAKIR)

Rheumatoid Arthritis

France
Gu Jieruo

Completed

Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis

Spondylitis

China
Oregon Health and Science University
Centocor, Inc.

Completed

A Clinical Trial of Infliximab for Uveitis

Uveitis
Copenhagen University Hospital at Herlev
Lundbeck Foundation; Danish Medical Association; Aase and Ejnar Danielsens Foundation and other collaborators

Unknown

Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy

Crohn's Disease

Denmark
Retina Research Foundation

Unknown

Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV) (ITVR)

Macular Degeneration | Diabetic Retinopathy

United States
Hospital General de Mexico
Schering-Plough

Completed

Efficacy, Safety, and Tolerability Study of Infliximab in Juvenile Spondyloarthropathies

Spondylarthropathies

Mexico
Imelda GI Clinical Research Center

Completed

Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Crohn Disease | Ulcerative Colitis

Belgium
Merck Sharp & Dohme LLC

Terminated

Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563)

Psoriasis
University of Pittsburgh
Centocor, Inc.

Completed

Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery

Crohn's Disease

United States

Search clinical trials for: Infliximab biosimilar

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations